Alto Neuroscience
ANRO
ANRO
83 hedge funds and large institutions have $45M invested in Alto Neuroscience in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
18
Reduced
27
Closed
12
Calls
$50K
Puts
$63K
Net Calls
-$13K
Net Calls Change
+$111K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$2.05M |
| 2 |
AIC
AWM Investment Company
New York
|
+$463K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$233K |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$216K |
| 5 |
SCM
SCS Capital Management
Boston,
Massachusetts
|
+$144K |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.72M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.03M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$977K |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$724K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$566K |
